Back to mobile site

Citi Maintains a 'Buy' on Celgene Corp (CELG), Attractive Buying Opportunity

January 12, 2009 2:00 PM EST Send to a Friend
Citi maintains a 'Buy' on Celgene Corp (Nasdaq: CELG). Price target $73.

Citi analyst says, "Today Celgene’s pre-announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login